USPTO serial 85399777
YANTAI DONGCHENG BIOCHEMICALS CO.,LTD.
Reviewed by CopyMark Law Group
Reg. 4224279Status 710
- Filing date
- Status date
- Registration date
- Oct 16, 2012
- Examiner
- KHAN, AHSEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with YANTAI DONGCHENG BIOCHEMICALS CO.,LTD.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Shandong, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Shandong, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Shandong, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Additives to fodder for medical purposes; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Chloramphenicol preparations; Dietetic foods adapted for medical purposes; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Medicinal drinks; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of gastrointestinal diseases; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, elixirs for the treatment of cancer; Pharmaceutical preparations, namely, injectable contraceptives; Tetracycline preparations; Thiolutin preparations; Threonine preparations | SECTION 8 - CANCELLED | Jul 21, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks in Class 005
- Similar marks named YANTAI DONGCHENG BIOCHEMICALS CO.,LTD.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 16, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 16, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 31, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 19, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 19, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 19, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 19, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 14, 2012 | PBTQ | WITHDRAWN FROM PUB OTQR REQUEST | — |
| May 2, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 27, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 2, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 14, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2011 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 22, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2011 | NWAP | NEW APPLICATION ENTERED | — |